GRIT Biotechnology
Latest round
- Series C
Last raised
- Sep 2025
Total raised
- $154M
Investors
- 14
About GRIT Biotechnology
Established in 2019 and based in Shanghai, China, GRIT Biotechnology is an innovative cell therapy company that engages in the development and application of tumor infiltration lymphocytes (TIL). It focuses on the Development of solid tumor immunotherapy., Decheng Capital, Hillhouse, and Sherpa Healthcare Partners, have cooperated with the company. The company mainly develops TIL therapies without genetic modification to treat malignant tumors. It has established three technology platforms to support the development of TIL therapies which are stable virus production cell lines, immunomodulatory target screening and Stemness TIL amplification technology. The company's products are currently undergoing clinical trials in China. GRIT Biotechnology will focus on the development of the company's tumor-infiltrating lymphocyte (TIL) therapy pipeline, including the pivotal clinical trial of GT101 and the development of several next-generation gene-edited TIL pipelines.
Who invested in GRIT Biotechnology
14 investors across 5 rounds
See all investors in GRIT Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GRIT Biotechnology
Who invested in GRIT Biotechnology?
GRIT Biotechnology has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GRIT Biotechnology raised?
GRIT Biotechnology has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did GRIT Biotechnology last raise money?
GRIT Biotechnology's most recent round on record is a Series C, in Sep 2025.
What does GRIT Biotechnology do?
Established in 2019 and based in Shanghai, China, GRIT Biotechnology is an innovative cell therapy company that engages in the development and application of tumor infiltration lymphocytes (TIL).
Where is GRIT Biotechnology headquartered?
GRIT Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like GRIT Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GRIT Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like GRIT Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.